EUVIMEDEUVIMED entdecken
Crossref

Betulinic acid and oleanolic acid modulate CD81 expression and induce apoptosis in triple-negative breast cancer cells through ROS generation

Dian Yuliartha Lestari, Gondo Mastutik, Indri Safitri Mukono

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02574-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Dian Yuliartha Lestari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Hauptthemen laut MEDLINE: Betulinic Acid, Triple Negative Breast Neoplasms, Apoptosis, Pentacyclic Triterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by a lack of hormones receptors and the HER2 receptor, making it unresponsive to targeted therapy. Triterpenoids such as betulinic acid (BA) and oleanolic acid (OA) have anticancer effects by inducing apoptosis in TNBC cells. CD81 is a tetraspanin that affects the growth and metastasis of cancer cells. To examine the effect of BA and OA on the viability of TNBC cell line (MDA-MB 231) by analyzing the CD81 expression, intracellular ROS, and apoptosis. The MDA-MB 231 cells was cultured and treated by BA and OA. The viability cell was evaluated by the CCK8 assay. This study analyzed the binding of BA and OA with CD81 using molecular docking and evaluated CD81 expression, intracellular ROS, and apoptosis by flow cytometry. The result showed that BA and OA inhibited viability of MDA-MB-231 cells. BA and OA bind to CD81 in silico, with binding affinities of 9.0 kcal/mol for BA and 7.2 kcal/mol for OA. Flow cytometry results revealed that BA can downregulate CD81 expression. BA and OA also increased intracellular ROS levels and induced apoptosis. These findings suggest that BA and OA, especially BA, can modulate CD81 expression and promote apoptosis in TNBC cells through the generation of ROS, thereby offering a potential therapeutic strategy for the treatment of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Betulinic AcidTriple Negative Breast NeoplasmsApoptosisPentacyclic TriterpenesTriterpenesReactive Oxygen SpeciesOleanolic AcidTetraspanin 28Molecular Docking SimulationHumansCell Line, TumorFemaleCell Survival

Stichwörter der Autor:innen

ApoptosisBetulinic acidCD81Oleanolic acidROSTriple-negative breast cancer

Substanzen

Betulinic AcidPentacyclic TriterpenesTriterpenesReactive Oxygen SpeciesOleanolic AcidTetraspanin 28CD81 protein, human

Autor:innen und Institutionen

  • Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Medical Faculty, University of Muhammadiyah Malang, Malang, Indonesia.
  • Department of Pathology Anatomy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Physiology and Medical Biochemistry, Faculty of Medicine, Univesitas Airlangga, Surabaya, Indonesia. indrisafitri@fk.unair.ac.id.

Zitieren

APA

Lestari, D. Y., Mastutik, G., & Mukono, I. S. (2024). Betulinic acid and oleanolic acid modulate CD81 expression and induce apoptosis in triple-negative breast cancer cells through ROS generation. Medical Oncology. https://doi.org/10.1007/s12032-024-02574-4

Vancouver

Lestari DY, Mastutik G, Mukono IS. Betulinic acid and oleanolic acid modulate CD81 expression and induce apoptosis in triple-negative breast cancer cells through ROS generation. Medical Oncology. 2024. doi:10.1007/s12032-024-02574-4

BibTeX
@article{Lestari2024,
  author = {Lestari, Dian Yuliartha and Mastutik, Gondo and Mukono, Indri Safitri},
  title = {Betulinic acid and oleanolic acid modulate CD81 expression and induce apoptosis in triple-negative breast cancer cells through ROS generation},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02574-4}
}
Kostenlos starten →